Candel Therapeutics, Inc. CADL Warrant Liability Noncurrent
Warrant Liability Noncurrent at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept cadl:WarrantLiabilityNoncurrent.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s warrant liability noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s warrant liability noncurrent?
- Candel Therapeutics, Inc. (CADL) reported warrant liability noncurrent of $7.96M in Q1 2026.
- What is the long-term trend for Candel Therapeutics, Inc.'s warrant liability noncurrent?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s warrant liability noncurrent has grown at a 18.0% compound annual growth rate (CAGR), from $6.83M to $15.6M.
- What does warrant liability noncurrent mean?
- This represents the fair value of outstanding warrants classified as noncurrent liabilities that are expected to be settled beyond the next twelve months. It reflects the long-term financial obligation associated with derivative instruments that do not meet the criteria for permanent equity classification. Changes in this valuation are typically driven by market volatility, the remaining term of the warrants, and the company's stock price performance.